全文获取类型
收费全文 | 246599篇 |
免费 | 21518篇 |
国内免费 | 8955篇 |
专业分类
耳鼻咽喉 | 1825篇 |
儿科学 | 3521篇 |
妇产科学 | 2876篇 |
基础医学 | 37667篇 |
口腔科学 | 3925篇 |
临床医学 | 19142篇 |
内科学 | 47493篇 |
皮肤病学 | 3486篇 |
神经病学 | 17719篇 |
特种医学 | 5283篇 |
外国民族医学 | 55篇 |
外科学 | 17734篇 |
综合类 | 31667篇 |
现状与发展 | 25篇 |
一般理论 | 48篇 |
预防医学 | 13583篇 |
眼科学 | 2941篇 |
药学 | 37941篇 |
61篇 | |
中国医学 | 9967篇 |
肿瘤学 | 20113篇 |
出版年
2023年 | 5385篇 |
2022年 | 7030篇 |
2021年 | 14001篇 |
2020年 | 11686篇 |
2019年 | 8231篇 |
2018年 | 7936篇 |
2017年 | 7755篇 |
2016年 | 7907篇 |
2015年 | 9163篇 |
2014年 | 14298篇 |
2013年 | 16139篇 |
2012年 | 13883篇 |
2011年 | 16042篇 |
2010年 | 13039篇 |
2009年 | 13276篇 |
2008年 | 12937篇 |
2007年 | 12142篇 |
2006年 | 10875篇 |
2005年 | 9483篇 |
2004年 | 8061篇 |
2003年 | 7229篇 |
2002年 | 5745篇 |
2001年 | 4803篇 |
2000年 | 4040篇 |
1999年 | 3514篇 |
1998年 | 2912篇 |
1997年 | 2853篇 |
1996年 | 2457篇 |
1995年 | 2517篇 |
1994年 | 2243篇 |
1993年 | 1899篇 |
1992年 | 1602篇 |
1991年 | 1462篇 |
1990年 | 1194篇 |
1989年 | 1004篇 |
1988年 | 941篇 |
1987年 | 784篇 |
1986年 | 712篇 |
1985年 | 1389篇 |
1984年 | 1442篇 |
1983年 | 1063篇 |
1982年 | 1048篇 |
1981年 | 910篇 |
1980年 | 779篇 |
1979年 | 659篇 |
1978年 | 502篇 |
1977年 | 396篇 |
1976年 | 428篇 |
1975年 | 375篇 |
1973年 | 265篇 |
排序方式: 共有10000条查询结果,搜索用时 918 毫秒
11.
[摘要] 目的 分析新型冠状病毒肺炎疫情(新冠疫情)暴发前、后2个年度,安庆市流行性感冒(流感)流行的强度和特征。方法 在“中国流感监测信息系统”中选取安庆市2019—2021年度监测数据,分析我市新冠疫情发生前、后的流感样病例就诊百分比、病原学阳性率和聚集性疫情的变化。结果 新冠疫情前、后2个年度,流感样病例就诊百分比分别为4.17%和3.78%,差异有统计学意义(χ2=56.652,P=0.000);病原学阳性率分别为23.43%和1.15%,差异有统计学意义(χ2=538.694,P=0.000)。新冠疫情前的流感病毒活动呈现双峰分布,新冠疫情后全年仅检出27份流感病毒阳性样本。结论 新冠疫情中采取的严格非药物预防措施,对流感的季节性特征有重要影响。应通过疫苗接种和非药物预防等措施,做好流感防控工作。 相似文献
12.
13.
《Vaccine》2022,40(18):2525-2527
14.
《Vaccine》2022,40(30):4038-4045
PurposeAs protection from COVID-19 following two doses of the BNT162b2 vaccine showed a time dependent waning, a third (booster) dose was administrated. This study aims to compare the antibody response following the third dose versus the second and to evaluate post-booster seroconversion.MethodsA prospective observational study conducted in Maccabi Healthcare Services. Serial SARS-CoV-2 Spike IgG tests, 1,2,3 and 6 months following the second vaccine dose and one month following the third were obtained. Neutralizing antibody levels were measured in a subset of participants. Per individual SARS-CoV-2 Spike IgG titer ratios were calculated one month after the booster administration compared to titers one month following the second dose and prior to booster.ResultsAmong 110 participants, 56 (51%) were women. Mean age was 61.7 ± 1.9 years and 66 (60%) were immunocompromised. One month after third dose, IgG titers were induced 7.83 (95 %CI 5.25–11.67) folds and 2.40 (95 %CI 1.90–3.03) folds compared to one month after the second, in the immunocompromised and immunocompetent groups, respectively. Of the 17 immunocompromised participants who were seronegative after the second dose, 4 (24%) became seropositive following the third. Comparing the titers prior to the third dose, an increase of 50.7 (95 %CI 32.5–79.1) fold in the immunocompromised group and 25.7 (95 %CI 19.1–34.7) fold in and immunocompetent group, was observed.ConclusionA third BNT162b2 vaccine elicited robust humoral response, superior to the response observed following the second, among immunocompetent and immunocompromised individuals. 相似文献
15.
《Health & place》2022
IntroductionWe extend previous research to illustrate how individual, interpersonal and neighbourhood factors in a high-density urban setting in Vancouver, Canada, shape social connectedness experiences of community-dwelling older adults during the first wave of the COVID-19 pandemic.MethodsWe conducted 31 semi-structured interviews and collected objective measures of loneliness and social connectedness (surveys).ResultsThree dimensions of the neighbourhood environment influenced social connectedness: (i) interactions with neighbours, (ii) involvement with neighbourhood-based organizations, and (ii) outdoor pedestrian spaces. Seventy-one percent of participants felt a strong sense of belonging to their local community, while 39% were classified as high or extremely lonely.SummaryMany participants leveraged pre-existing social ties to maintain connections during the pandemic. However, volunteer outreach was vital for more isolated older adults. Although many participants felt lonely and isolated at times, the relative ease and accessibility with which they could connect with others in their neighbourhood environment, may have helped mitigate persistent loneliness.ConclusionStrategies that foster social connectedness over the longer term, need to prioritize the needs of older adults who face multiple barriers to equitable social participation. 相似文献
16.
17.
18.
19.
Given that the global population of elderly individuals is expanding and the difficulty of recovery, hip fractures will be a huge challenge and a critical health issue for all of humanity. Although people have spent more time at home during the coronavirus disease 2019 (COVID-19) pandemic, hip fractures show no sign of abating. Extensive studies have shown that patients with hip fracture and COVID-19 have a multifold increase in mortality compared to those uninfected and a more complex clinical condition. At present, no detailed research has systematically analyzed the relationship between these two conditions and proposed a comprehensive solution. This article aims to systematically review the impact of COVID-19 on hip fracture and provide practical suggestions. We found that hip fracture patients with COVID-19 have higher mortality rates and more complicated clinical outcomes. Indirectly, COVID-19 prevents hip fracture patients from receiving regular medical treatment. With regard to the problems we encounter, we provide clinical recommendations based on existing research evidence and a clinical flowchart for the management of hip fracture patients who are COVID-19 positive. Our study will help clinicians adequately prepare in advance when dealing with such patients and optimize treatment decisions. 相似文献
20.
《Journal of infection and chemotherapy》2022,28(4):548-553
IntroductionCOVID-19 patients have been reported to have digestive symptoms with poor outcome. Ivermectin, an antiparasitic drug, has been used in COVID-19 patients. The objective of this study was to evaluate whether ivermectin has effects on gastrointestinal complications and ventilator-free days in ventilated patients with COVID-19.MethodsCOVID-19 patients who were mechanically ventilated in the ICU were included in this study. The ventilated patients who received ivermectin within 3 days after admission were assigned to the Ivermectin group, and the others were assigned to the Control group. Patients in the Ivermectin group received ivermectin 200 μg/kg via nasal tube. The incidence of gastrointestinal complications and ventilator-free days within 4 weeks from admission were evaluated as clinical outcomes using a propensity score with the inverse probability weighting method.ResultsWe included 88 patients in this study, of whom 39 patients were classified into the Ivermectin group, and 49 patients were classified into the Control group. The hazard ratio for gastrointestinal complications in the Ivermectin group as compared with the Control group was 0.221 (95% confidence interval [CI], 0.057 to 0.855; p = 0.029) in a Cox proportional-hazard regression model. The odds ratio for ventilator-free days as compared with the Control group was 1.920 (95% CI, 1.076 to 3.425; p = 0.027) in a proportional odds logistic regression model.ConclusionsIvermectin improved gastrointestinal complications and the number of ventilator-free days in severe COVID-19 patients undergoing mechanical ventilation. Prevention of gastrointestinal symptoms by SARS-Cov-2 might be associated with COVID-19 outcome. 相似文献